Guardant Health Inc (NASDAQ:GH) price on Wednesday, May 09, fall -0.96% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $18.64.
A look at the stock’s price movement, the close in the last trading session was $18.82. Turning to its 52-week performance, $41.06 and $15.81 were the 52-week high and 52-week low respectively. Overall, GH moved -2.92% over the past month.
Guardant Health Inc’s market cap currently stands at around $2.27 billion.
Analysts have a consensus estimate of 150.67M for the company’s revenue for the quarter, with a low and high estimate of 147.6M and 161.9M respectively. The average forecast suggests up to a 17.10% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 664.02M, representing a 17.70% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that GH is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
GH’s current price about 4.79% and 1.70% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 52.88, while 7-day volatility ratio is 3.46% and 5.04% in the 30-day chart. Further, Guardant Health Inc (GH) has a beta value of 1.05, and an average true range (ATR) of 0.96.
If we refocus on Guardant Health Inc (NASDAQ:GH), historical trading data shows that trading volumes averaged 1.92 million over the past 3 months. The company’s latest data on shares outstanding shows there are 121.63 million shares.
The 4.79% of Guardant Health Inc’s shares are in the hands of company insiders while institutional holders own 92.51% of the company’s shares. Current price change has pushed the stock -31.09% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the GH stock continues to rise going into the next quarter.
